VITRIFICATION MARTINA FILOV REPROFIT INTERNATIONAL S.R.O. - - PowerPoint PPT Presentation

vitrification
SMART_READER_LITE
LIVE PREVIEW

VITRIFICATION MARTINA FILOV REPROFIT INTERNATIONAL S.R.O. - - PowerPoint PPT Presentation

THE ART of EGG VITRIFICATION MARTINA FILOV REPROFIT INTERNATIONAL S.R.O. Vitrification - principals ES= 7.4% EG/7.4% DMSO VS= 14.5% EG/14.5% DMSO/0.5M trehalose DS= 0.5M trehalose TS= 1,0M trehalose , T= 37C Kitazato close and


slide-1
SLIDE 1

THE ART of EGG VITRIFICATION

MARTINA FILOVÁ REPROFIT INTERNATIONAL S.R.O.

slide-2
SLIDE 2

Vitrification - principals

ES= 7.4% EG/7.4% DMSO VS= 14.5% EG/14.5% DMSO/0.5M trehalose
  • TS= 1,0M trehalose, T= 37⁰C
  • DS= 0.5M trehalose
slide-3
SLIDE 3

Kitazato close and open system

slide-4
SLIDE 4

System &Product variety

Systems:

  • 1. Fully open system – Cryotop, Cryotech, Cryolock
  • 2. Open cooling and close storage system – CryotopSC, OPS

3.Semi-closed cooling – Cryohook, Vitrolife, Cryotop 4.Closed thin walled , narrow capillaries- Cryotip, Cryopette 5.Carrier tools sealed into a container - High security virtrification kit, Vitrisystems -- close

Media -- Kitazato Vitrolife Irvine Sage

slide-5
SLIDE 5

Trustworthiness - Reliability

Commercial availability ≠ reliability

slide-6
SLIDE 6

Validation in the Lab – satisfactory, adequate ???

Short time - 10 – 20 cases Eggs - immature (MI,GV) FTF after IVF Survival – main paramater ! poor development no blastulation

slide-7
SLIDE 7

Kitazato - Close

CLOSE

  • 6.11.2017- 7.2.2018

24 donors – 216 oocytes 198 warmed out Results

  • unsatisfactory

( inconsistent)

slide-8
SLIDE 8

Is cooling and warming rate the main factor??

slide-9
SLIDE 9

The magic of making bread

slide-10
SLIDE 10

Factors applying to successful vitrification

slide-11
SLIDE 11

Temperature

slide-12
SLIDE 12

Humidity

slide-13
SLIDE 13

Loading - crucial step

slide-14
SLIDE 14

Kitazato – close/open

CLOSE/OPEN - 21.2.2018- 20.3.2018 12 donors – 105 oocytes 105 warmed out

Close Open

  • o/cycle

36/7

5,1

53/10

5,3

SR (%) 26/36

72%

50/53

94%

FR (%) 11/26

42%

44/50

88%

BR (%) 8/26

30%

28/50

56%

UR ICSIoo (%) 3/26

12%

14/50

28%

UR Vitri Oo (%) 3/36

9%

14/53

26%

slide-15
SLIDE 15

Open system study

OPEN - 10.4.2018 68 donors – 802 oocytes 437 warmed out

slide-16
SLIDE 16

Results

slide-17
SLIDE 17

Pregnancy rate

slide-18
SLIDE 18

Biosafety

All medical intervention means a certain risk to the patient, it is duty of the health service provider to make the right decision between the possible benefits and the chances of harm

slide-19
SLIDE 19

Thank you!